Anti-oxLDL antibodies are clinically insignificant for stroke patients

Neurological Research

Volumn 36, Issue 1, 2014, Pages 86-91

  Masztalewicz, Marta ^a   Nowacki, Przemysław ^a   Kotlega, Dariusz ^a   Bajer Czajkowska, Anna ^a   Drechsler, Hanna ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Anti oxLDL antibodies; Carotid atherosclerosis; Stroke

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; IMMUNOGLOBULIN G; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTERY OCCLUSION; ARTICLE; BRAIN ISCHEMIA; CAROTID ATHEROSCLEROSIS; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DOPPLER FLOWMETRY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN EXPRESSION; RISK FACTOR;

ANTI-OXLDL ANTIBODIES,; CAROTID ATHEROSCLEROSIS,; STROKE;

AGED; AUTOANTIBODIES; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CAROTID ARTERIES; CAROTID STENOSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; ULTRASONOGRAPHY, DOPPLER;

EID: 84892957304     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132813Y.0000000268     Document Type: Article

References (27)

1. Nishi K, Itabe H, Uno M, Kitazato KT, Horiguchi H, Shinno K, et al. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler Thromb Vasc Biol. 2002;22:1649-54.
2. Fang R, Zhang N, Wang C, Zhao X, Liu L, Wang Y, et al. Relationship between plasma ox-LDL and carotid plaque among Chinese Han ethnic group. Neurol Res. 2011;33(5): 460-6.
3. Che J, Li G, Wang W, Li Q, Liu H, Chen K, et al. Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by Gensini score. Cardiol J. 2011;18(4):364-70.
4. Ferreira PF, Zago VH, D'Alexandri FL, Panzoldo NB, Gidlund MA, Nakamura RT, et al. Oxidized low-density lipoproteins and their antibodies: relationships with the reverse cholesterol transport and carotid atherosclerosis in adults without cardiovascular diseases. Clin Chim Acta. 2012; 413(19-20):1472-8.
5. Ahmed HM, Youssef M, Mosaad YM. Antibodies against oxidized low-density lipoprotein are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis. Clin Rheumatol. 2010;29(11):1237-43.
6. Ahmed E, Trifunovic J, Stegmayr B, Hallmans G, Lefvert AK. Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: a nested case-control study. Stroke. 1999;30(12):2541-6.
7. Cojocaru IM, Cojocaru M, Burcin C. IgG-autoantibodies against oxidized low-density lipoprotein in ischemic stroke onset. Rom J Intern Med. 2006;44(2):166-70.
8. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon D. Classification of subtype of acute ischemic stroke. Definitions for use in amulticenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
9. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-87.
10. World Health Organisation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. ISBN 978 92 4 159493 6, WHO Press, Geneva, Switzerland.
11. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Atherosclerosis. 2007;194(1):1-45.
12. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4thWatching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis. 2007;23(1):75-80.
13. Sztajzel R. Ultrasonographic assessment of the morphological characteristics of the carotid plaques. Swiss Med Wkly. 2005; 135:635-43.
14. Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis-Society of Radiologists in Ultrasound Consensus Conference. Radiology. 2003;229:340-6.
15. Zhou X, Caligiuri G, Hamsten A, Lefvert AK, Hansson GK. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol. 2001;21:108-14.
16. Shoji T, Nishizawa Y, Fukomoto M, Shimamura K, Kimura J, Kanda H, et al. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis. 2000; 148(1):171-7.
17. Fukumoto M, Shoji T, Emoto M, Kawagishi T, Okuno Y, Nishizawa Y. Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. Arterioscler Thromb Vasc Biol. 2000;20:703-7.
18. Rerkasem K, Gallagher PJ, Grimble RF, Calder PC, Shearman CP. The relationship between carotid plaque calcification and stability. Thai J Surg. 2011;32(4):131-6.
19. Mathiesen EB, Bønaa KH, Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the tromsø study. Circulation. 2001;103: 2171-5.
20. Pawlak K, Myśliwiec M, Pawlak D. Oxidized LDL to autoantibodies against oxLDL ratio-the new biomarker associated with carotid atherosclerosis and cardiovascular complication in dialyzed patients. Atherosclerosis. 2012;224(1): 252-7.
21. Wonish W, Falk A, Sundl I, Winklhofer-Roob BM, Lindschinger M. Oxidative stress increases continuously with BMI and age with unfavourable profiles in males. Aging Male. 2012;15(3):159-65.
22. Assadpoor-Pirnfar M, Pordal AH, Beyranvand MR. Measurement of oxidized low-density lipoprotein and superoxide dismutase activity in patients with hypertension. Arch Iran Med. 2009;12(2):116-20.
23. Nakhjavani M, Khalizadeh O, Khajeali L, Esteghamati A, Morteza A, Jamali A, et al. Serum oxidized-LDL is associated with diabetes duration independent of maintaining optimized levels of LDL-cholesterol. Lipids. 2010;45(4):321-7.
24. Santos AO, Fonseca FA, Fisher SM, Monteiro CM, Brandão SA, Póvoa RM, et al. High circulating autoantibodies against human oxidized low density lipoprotein are related to stable and lower titers to unstable clinical situation. Clin Chim Acta. 2009;406(1-2):113-8.
25. Samson S, Mundkur L, Kakkar VV. Immune response to lipoproteins in atherosclerosis. Cholesterol. 2012;2012:571846.
26. Soltesz P, Veres K, Laczik R, Der H, Csipo I, Timar O, et al. Evaluation of antibodies to oxidized low-density lipoprotein and assessment of C-reactive protein in acute coronary syndrome and stable coronary artery disease. Thromb Haemost. 2007;98(2):413-9.
27. Fleiner M, Kummer M, Mirlacher M. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation. 2004;110(18): 2843-50